Mechanisms of angiotensin II type 1 receptor blocker for anti-atherosclerotic effect in monkeys fed a high-cholesterol diet
- 1 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 21 (2) , 361-369
- https://doi.org/10.1097/00004872-200302000-00028
Abstract
Objective To clarify the mechanism of the anti-atherosclerotic effect of angiotensin II type 1 receptor blocker (ARB) in primates, we investigated whether an ARB (CS-866) affects the serum markers of inflammation and growth factors, and the endothelial function in monkeys fed a high-cholesterol diet. Design Monkeys fed a high-cholesterol diet for 6 months were divided into two groups: one group was given an ARB, CS-866 (10 mg/kg per day), and the other group was not. The control group was fed a normal diet. Results Blood pressure and the plasma cholesterol level were not affected by CS-866. Plasma levels of angiotensin II, renin, angiotensin converting enzyme and chymase were not changed by the high-cholesterol diet, whereas vascular angiotensin converting enzyme, but not chymase, was significantly increased. Serum levels of macrophage-colony stimulating factor, transforming growth factor-β1 and intracellular adhesion molecule-1 were significantly increased in monkeys fed a high-cholesterol diet but they were suppressed by CS-866. The relaxation response of isolated carotid arteries to acetylcholine was suppressed in the high-cholesterol group, whereas it was improved by CS-866. Conclusions CS-866 reduced lipid deposition along with the suppression of serum macrophage-colony stimulating factor, transforming growth factor-β1 and intracellular adhesion molecule-1, and the improvement of vascular functions, suggesting that ARB has multiple mechanisms for reducing lipid deposition in primates.Keywords
This publication has 29 references indexed in Scilit:
- Transforming Growth Factor β in Hypertensives With Cardiorenal DamageHypertension, 2000
- C-Reactive Protein in the Arterial IntimaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilationJournal of Clinical Investigation, 1999
- Anti‐atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high‐cholesterol dietBritish Journal of Pharmacology, 1999
- Negative Regulation of Local Hepatocyte Growth Factor Expression by Angiotensin II and Transforming Growth Factor-β in Blood VesselsHypertension, 1998
- Angiotensin II Increases Monocyte Binding to Endothelial CellsBiochemical and Biophysical Research Communications, 1996
- Pathobiology of atherosclerosis and plaque complicationsAmerican Heart Journal, 1994
- Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemotactic protein-1 and increases the adhesion of monocytes to endothelial monolayers.Journal of Clinical Investigation, 1993
- Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteinsNature, 1990
- Effects of antihypertensive drugs on blood velocity in rhesus monkeys.Stroke, 1977